Carole Kringel

Carole Kringel is a Clinical Research Coordinator with extensive experience in conducting clinical trials in adherence to ICH-GCP, IRB, and FDA guidelines. Currently at Roskamp Institute since August 2021, Carole serves as the Primary Study Coordinator for Phase III Alzheimer and Open Label Multiple Sclerosis studies. Previous roles include Clinical Research Coordinator at The Eye Associates, where responsibilities involved budget preparation and protocol submissions for ophthalmic studies, and Clinical Monitoring Associate at PAREXEL, focusing on site selection and patient enrollment for Oncology studies. Earlier experience as a Certified Ophthalmic Technician includes patient consultations and surgical assistance in refractive and cataract surgeries, along with participation in various clinical trials. Carole holds a Bachelor of Science in Psychology and Chemistry from Florida State University and an Associate of Arts in Biology from Palm Beach State College.